ATHX Athersys Inc.

1.87
+0.01  (+1%)
Previous Close 1.86
Open 1.9
Price To Book 7.48
Market Cap 280081556
Shares 149,776,233
Volume 585,310
Short Ratio
Av. Daily Volume 766,833

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2/3 enrollment commenced November 2017 (Japan).
Multistem - TREASURE (Japan)
Ischemic stroke
Phase 3 MASTERS-2 trial initiation announced July 31, 2018.
Multistem
Ischemic stroke
Phase 2 enrollment continues but reported May 2018 that enrollment is slower than expected.
Multistem
Acute myocardial infarction
Phase 2 ONE-BRIDGE commencement of enrolment announced April 23, 2019.
Multistem
Acute Respiratory Distress Syndrome